Skip to main content
SpringerLink
Log in

Sitzungsbericht der AG Knochen-, Gelenk- und Weichgewebspathologie

DGP-Tagung am 19. Mai 2016

Minutes of the AG Knochen-, Gelenk- und Weichgewebspathologie

DGB-Conference on 19 May 2016

  • Berichte der Arbeitsgemeinschaften
  • Published:
Der Pathologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Agaimy A, Daum O, Märkl B, Lichtmannegger I, Michal M, Hartmann A (2016) SWI/SNF complex-deficient undifferentiated/rhabdoid carcinomas of the gastrointestinal tract: a series of 13 cases highlighting mutually exclusive loss of SMARCA4 and SMARCA2 and frequent co-inactivation of SMARCB1 and SMARCA2. Am J Surg Pathol 40(4):544–553

    Article  PubMed  Google Scholar 

  2. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, van Loo P, Wedge DC, Cooke SL, Gundem G, Davies H, Nik-Zainal S, Martin S, McLaren S, Goody V, Robinson B, Butler A, Teague JW, Halai D, Khatri B, Myklebost O, Baumhoer D, Jundt G, Hamoudi R, Tirabosco R, Amary MF, Futreal PA, Stratton MR, Campbell PJ, Flanagan AM (2013) Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet 45(12):1479–1482

    Article  CAS  PubMed  Google Scholar 

  3. Durston AJ, Jansen HJ, In der Rieden P, Hooiveld MH (2011) Hox collinearity – a new perspective. Int J Dev Biol 55(10–12):899–908

    Article  CAS  PubMed  Google Scholar 

  4. Fanelli M, Hattinger CM, Vella S, Tavanti E, Michelacci F, Gudeman B, Barnett D, Picci P, Serra M (2016) Targeting ABCB1 and ABCC1 with their specific inhibitor CBT-1(®) can overcome drug resistance in osteosarcoma. Curr Cancer Drug Targets 16(3):261–274

    Article  CAS  PubMed  Google Scholar 

  5. Ferrari S, Serra M (2015) An update on chemotherapy for osteosarcoma. Expert Opin Pharmacother 16(18):2727–2736

    Article  CAS  PubMed  Google Scholar 

  6. Haller F, Knopf J, Ackermann A, Bieg M, Kleinheinz K, Schlesner M, Moskalev EA, Will R, Satir AA, Abdelmagid IE, Giedl J, Carbon R, Rompel O, Hartmann A, Wiemann S, Metzler M, Agaimy A (2016) Paediatric and adult soft tissue sarcomas with NTRK1 gene fusions: a subset of spindle cell sarcomas unified by a prominent myopericytic/haemangiopericytic pattern. J Pathol 238(5):700–710

    Article  CAS  PubMed  Google Scholar 

  7. Hattinger CM, Serra M (2015) Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma. Expert Opin Drug Metab Toxicol 11(9):1449–1463

    Article  CAS  PubMed  Google Scholar 

  8. Hattinger CM, Fanelli M, Tavanti E, Vella S, Ferrari S, Picci P, Serra M (2015) Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Drugs 20(3):495–514

    Article  CAS  PubMed  Google Scholar 

  9. Hattinger CM, Michelacci F, Sella F, Magagnoli G, Benini S, Gambarotti M, Palmerini E, Picci P, Serra M, Ferrari S (2015) Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy. Histopathology 67(3):338–347

    Article  PubMed  Google Scholar 

  10. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, Triche TJ (2005) WS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing’s family of tumors. Cancer Res 65(11):4633–4644

    Article  CAS  PubMed  Google Scholar 

  11. Kovac M, Blattmann C, Ribi S, Smida J, Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M, Krieg A, Andreou D, Tunn PU, Dürr HR, Rechl H, Schaser KD, Melcher I, Burdach S, Kulozik A, Specht K, Heinimann K, Fulda S, Bielack S, Jundt G, Tomlinson I, Korbel JO, Nathrath M, Baumhoer D (2015) Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun 3(6):8940

    Article  Google Scholar 

  12. Makris EA, Hadidi P, Athanasiou KA (2011) The knee meniscus: structure-function, pathophysiology, current repair techniques, and prospects for regeneration. Biomaterials 32(30):7411–7431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Straub BK (2015) Lipid droplet-associated proteins : Importance in steatosis, steatohepatitis and hepatocarcinogenesis. Pathologe 36(Suppl 2):146–152

    Article  PubMed  Google Scholar 

  14. Straub BK, Herpel E, Singer S, Zimbelmann R, Breuhahn K, Macher-Goeppinger S, Warth A, Lehmann-Koch J, Longerich T, Heid H, Schirmacher P (2010) Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesis. Mod Pathol 23(3):480–492

    Article  CAS  PubMed  Google Scholar 

  15. Straub M, Drecoll E, Pfarr N, Weichert W, Langer R, Hapfelmeier A, Götz C, Wolff KD, Kolk A, Specht K (2016) CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity. Oncotarget 7(11):12024–12034

    PubMed  PubMed Central  Google Scholar 

  16. von Witzleben A, Goerttler LT, Lennerz J, Weissinger S, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Möller P, Barth TF (2015) In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients’ shorter overall survival. Eur Spine J 23 doi:10.1007/s00586-015-4242-1

    Google Scholar 

  17. von Witzleben A, Goerttler LT, Marienfeld R, Barth H, Lechel A, Mellert K, Böhm M, Kornmann M, Mayer-Steinacker R, von Baer A, Schultheiss M, Flanagan AM, Möller P, Brüderlein S, Barth TF (2015) Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway. Cancer Res 75(18):3823–3831

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pathologie und Zytologie, Helios Dr. Horst Schmidt Kliniken Wiesbaden, Ludwig-Erhard-Str. 100, 65199, Wiesbaden, Deutschland

    S. Scheil-Bertram

  2. MVZ für Histologie, Zytologie & Molekulare Diagnostik, Trier, Deutschland

    V. Krenn

Authors
  1. S. Scheil-Bertram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Krenn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Scheil-Bertram.

Ethics declarations

Interessenkonflikt

S. Scheil-Bertram und V. Krenn geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

The supplement containing this article is not sponsored by industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scheil-Bertram, S., Krenn, V. Sitzungsbericht der AG Knochen-, Gelenk- und Weichgewebspathologie. Pathologe 37 (Suppl 2), 242–246 (2016). https://doi.org/10.1007/s00292-016-0193-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-016-0193-5

Search

Navigation